|
Sign In to gain access to subscriptions and/or personal tools.
|
Journal of Intensive Care Medicine, Vol. 19, No. 3,
164-170 (2004)
DOI: 10.1177/0885066604263828
Preliminary Experience With Nesiritide in the Pediatric Population
Julie Marshall
University of Missouri School of Medicine
John W. Berkenbosch, MD
Department of Child Health, University of Missouri, Columbia, Missouri
Pierantonio Russo, MD
Department of Cardiothoracic Surgery, University of Missouri, Columbia, Missouri
Joseph D. Tobias, MD
Department of Anesthesiology, University of Missouri, Columbia, Missouri, tobiasj{at}health.missouri.edu
Nesiritide is a recombinant formulation of brain-type natriuretic factor. Preliminary experience in the adult population suggests that nesiritide may be an effective agent in the treatment of decompensated congestive heart failure. Given its physiologic effects, it may be an effective agent in the pediatric population; however, to date, there are no reports regarding its use in infants and children. The authors retrospectively review their experience with nesiritide in 5 pediatric patients. The cohort of 5 patients included a diverse population with 2 patients who were status postcardiothoracic surgery, 2 with adult respiratory distress syndrome, and 1 in the recovery phase from septic shock. Although no direct measurement of cardiac output was feasible as none of the patients had a pulmonary artery catheter, other indicators of increased cardiac output were noted. These included improved peripheral perfusion with warming of the extremities and improvement of peripheral pulses in all of the patients, increased venous saturation in 2 of the patients, and maintenance of or increased urine output despite weaning or discontinuation of diuretics. In 3 of the patients, nesiritide was started as the primary agent to provide a decrease in systemic vascular resistance and augment cardiac output, while in the other 2 patients, nesiritide was used when other vasoactive agents failed to provide the desired effect or resulted in adverse effects.
Key Words: nesiritide • congenital heart disease • septic shock • high-frequency ventilation
References
- 1. Mills RM, Hobbs RE. How to use nesiritide in treating decompensated heart failure . Clev Clin J Med. 2002;69: 252-256 .[Medline]
[Order article via Infotrieve]
- 2. Publication Committee for VMAC Investigators. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial . JAMA. 2002;287: 1531-1540 .[Abstract/Free Full Text]
- 3. Cowie MR, Mendez GF. BNP and congestive heart failure . Prog Cardiovasc Dis. 2002;44: 293-321 .[CrossRef][Medline]
[Order article via Infotrieve]
- 4. Maack T. Receptors of atrial natriuretic factor . Ann Rev Physiol. 1992;54: 11-27 .[CrossRef][Medline]
[Order article via Infotrieve]
- 5. Koller KJ, Goeddel DV. Molecular biology of the natriuretic peptides and their receptors . Circulation. 1992;86: 1081-1088 .[Abstract/Free Full Text]
- 6. Silver MA, Horton DP, Ghali JK, Elkayam U. Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure . J Am Coll Cardiol. 2002;39: 798-803 .[Abstract/Free Full Text]
- 7. Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure: the PROMISE study research group . N Engl J Med. 1991;325: 1468-1475 .[Medline]
[Order article via Infotrieve]
- 8. Burger AJ, Elkayam U, Neibaur MT, et al. Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy . Am J Cardiol. 2001;88: 35-39 .[Medline]
[Order article via Infotrieve]
- 9. Burger A, Dennish G, Horton D, et al. Nesiritide therapy for decompensated CHF is not proarrhythmic . J Am Coll Cardiol. 2000;35: 172 .
- 10. Kabane S, Matsushima Y, Matsuo H, et al. Effects of brain natriuretic peptide on renin secretion in normal and hypertonic saline-infused kidney . Eur J Pharm. 1991;198: 143-148 .[CrossRef][Medline]
[Order article via Infotrieve]
- 11. Hashiguchi T, Higuchi K, Ohashi M, et al. Effect of porcine brain natriuretic peptide (pBNP) on human adrenocortical steroidogenesis . Clin Endocrin. 1989;31: 623-630 .
- 12. Tobias JD. Nicardipine to control mean arterial pressure after cardiothoracic surgery in infants and children . Am J Ther. 2001;8: 3-6 .[CrossRef][Medline]
[Order article via Infotrieve]
- 13. Cooper HA, Dries DL, Davis CE, et al. Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction . Circulation. 1999;100: 1311-1315 .[Abstract/Free Full Text]
- 14. Mehta RL, Rascual MT, Soroko S, et al. Diuretics, mortality, and nonrecovery of renal function in acute renal failure . JAMA. 2002;288: 2547-2553 .[Abstract/Free Full Text]
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
R. D. Mainwaring, C. Parise, S. B. Wright, A. L. Juris, R. A. Achtel, and H. Fallah
Brain Natriuretic Peptide Levels Before and After Ventricular Septal Defect Repair
Ann. Thorac. Surg.,
December 1, 2007;
84(6):
2066 - 2069.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Simsic, M. Scheurer, J. D. Tobias, J. Berkenbosch, W. Schechter, F. Madera, S. Weinstein, and R. E. Michler
Perioperative effects and safety of nesiritide following cardiac surgery in children.
J Intensive Care Med,
January 1, 2006;
21(1):
22 - 26.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. S. Schamberger
Is There a Use for Nesiritide in Pediatric Patients?
J Intensive Care Med,
May 1, 2004;
19(3):
171 - 173.
[PDF]
|
|
|
|
